Request for Information on the Proposed Framework for Developing Study Content and Protocols for the National Children's Study, 3840-3842 [2014-01339]
Download as PDF
sroberts on DSK5SPTVN1PROD with NOTICES
3840
Federal Register / Vol. 79, No. 15 / Thursday, January 23, 2014 / Notices
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Wei-Qin Zhao, Ph.D.,
Scientific Review, Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5181
MSC 7846, Bethesda, MD 20892–7846, 301–
435–1236, zhaow@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Drug
Related Small Business Review.
Date: February 14, 2014.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Yuan Luo, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5207, MSC 7846, Bethesda, MD
20892, 301–915–6303, luoy2@mail.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group, Chronic Dysfunction and Integrative
Neurodegeneration Study Section.
Date: February 18–19, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Alexei Kondratyev, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5200,
MSC 7846, Bethesda, MD 20892, 301–435–
1785, kondratyevad@csr.nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group, Somatosensory and
Chemosensory Systems Study Section.
Date: February 18–19, 2014.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Long Beach and Executive
Center, 701 West Ocean Boulevard, Long
Beach, CA 90831.
Contact Person: M. Catherine Bennett,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182,
MSC 7846, Bethesda, MD 20892, 301–435–
1766, bennettc3@csr.nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group, Bioengineering,
Technology and Surgical Sciences Study
Section.
Date: February 18–19, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Sheraton San Diego Hotel and
Marina, 1380 Harbor Island Drive, San Diego,
CA 92101.
Contact Person: Khalid Masood, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
VerDate Mar<15>2010
21:50 Jan 22, 2014
Jkt 232001
Health, 6701 Rockledge Drive, Room 5120,
MSC 7854, Bethesda, MD 20892, 301–435–
2392, masoodk@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Cardiovascular Sciences.
Date: February 18, 2014.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Lawrence E. Boerboom,
Ph.D., Chief, CVRS IRG, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 4130, MSC 7814,
Bethesda, MD 20892, (301) 435–8367,
boerboom@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PAR–11–
100: Alzheimer’s Disease Pilot Clinical
Trials.
Date: February 18, 2014.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Mark Lindner, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182,
MSC 7770, Bethesda, MD 20892, 301–435–
0913, mark.lindner@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846-93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 16, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–01187 Filed 1–22–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Request for Information on the
Proposed Framework for Developing
Study Content and Protocols for the
National Children’s Study
The National Children’s
Study (NCS) is soliciting comments and
suggestions from the public on the
proposed Study content framework. The
questions solicited in this Request for
Information (RFI) focus on the validity
and acceptability of the using a
composite outcome for the higher-level
functions of a healthy 21-year-old
person as an important operational
construct to help frame data collection
throughout the duration of the study.
SUMMARY:
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
Responses to this RFI will be used to
inform Study protocol development.
DATES: The National Children’s Study
Request for Information is open for
public comment for a period of 30 days.
Comments must be received by
February 24, 2014 to ensure
consideration. After the public comment
period has closed, the comments
received by the NCS will be considered
in a timely manner by the Eunice
Kennedy Shriver National Institute of
Child Health and Human Development
and the National Children’s Study.
ADDRESSES: Questions about this request
for information should be directed to
Kate Winseck, MSW, The National
Children’s Study, Eunice Kennedy
Shriver National Institute of Child
Health and Human Development,
National Institutes of Health, 6100
Executive Blvd., Rm. 5C01, Bethesda,
MD 20891, NCS_RFI@mail.nih.gov,
301–594–9147.
SUPPLEMENTARY INFORMATION: The
National Children’s Study is a
congressionally-mandated longitudinal
birth cohort study intended to examine
the effects of environmental exposures
on the growth, development, and
wellbeing of children. The NCS was
mandated by the Children’s Health Act
of 2000 (Pub. L. 106–310).
1. Goals and Requirements
The primary objective of the NCS is
to conduct a national longitudinal study
of environmental influences (including
physical, chemical, biological, and
psychosocial) on children’s health and
development. These factors include
environmental exposures (with a broad
definition of environment) and
biological/genetic contexts. The Study
objectives stated in the Children’s
Health Act of 2000 include: (1) Evaluate
the effects of both chronic and
intermittent exposures on child health
and human development; (2) investigate
basic mechanisms of developmental
disorders and environmental factors; (3)
incorporate behavioral, emotional,
educational, and contextual
consequences to enable a complete
assessment of the physical, chemical,
biological and psychosocial
environmental influences on children’s
well-being; (4) gather data from diverse
populations of children including
prenatal exposures; and (5) consider
health disparities among children.
2. Proposed Study Content Framework
The NCS proposes to organize data
collection priorities to support
measurement of health and healthy
development at critical stages. This
requires understanding and identifying
E:\FR\FM\23JAN1.SGM
23JAN1
sroberts on DSK5SPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 15 / Thursday, January 23, 2014 / Notices
known and potential factors that may
influence health outcomes and
characteristics along the developmental
spectrum. For example, data collected
during pregnancy are designed to look
not only at antecedents of disease but
also to look for factors associated with
health. Which exposures are associated
with a healthy, full term infant? What
factors are predictive of a normal birth
weight? What factors are associated with
normal neurologic development? Areas
that will be examined include, but are
not limited to (1) physical factors such
as maternal and paternal height, weight
and Body Mass Index (BMI); (2) health
behaviors such as sleep, diet and
physical activity; (3) outcomes of past
pregnancies and other medical
conditions and history; (4) medication
use (including alternative and
complementary medicines); (5) presence
or absence of components of the
physical environment, such as noise,
mold and mildew, pets, chemicals, and
environmental tobacco smoke; and (6)
psychosocial factors, such as social
support, social networks, and
psychological well-being and other
factors that may protect and mediate
reactions to stress. Biological and
environmental samples will be collected
to allow examination of in-utero
exposures.
The NCS intends to follow all
children from birth until they reach age
21, an endpoint consistent with the
Food and Drug Administration
Amendments Act of 2007 that defines
‘‘pediatric patients’’ as ‘‘those who are
21 years of age or younger at the time
of diagnosis or treatment (FDA
Amendments Act of 2007).’’ As such it
is important to identify the
characteristics of a healthy 21-year-old
person. Reaching age 21 is one of many
important developmental milestones
and it serves as a useful life stage for
illustration of how the NCS data
collection framework can be organized.
To ensure the Study content
framework is comprehensive, the NCS is
working with subject matter experts to
characterize health. As developmental
trajectories are multi-dimensional,
multi-directional, and multi-level, this
effort not only helps characterize the
distal end of the childhood
developmental trajectory, but also
identifies potential antecedent factors
that could be measured earlier in life in
assessing exposures that may contribute
to later outcomes. For example,
supportive family relationships during
adolescence has been associated with
positive outcomes ranging from reduced
risk of poor mental health to higher
levels of interpersonal and occupational
functioning; these outcomes being
VerDate Mar<15>2010
21:50 Jan 22, 2014
Jkt 232001
independent of any effect of gender,
socioeconomic status, or family
disruption, for example death or divorce
(Child Adolescent Mental Health 16(1):
30–37).
At 21 years old, the thriving
individual is a manifestation of
complex, dynamic, non-linear
developmental processes that are
products of personal characteristics
(including genetics), person-to-person,
and person-to-environment interactions
in the broadest sense. This
characterization is consistent with the
World Health Organization (WHO)
construct (https://www.who.int/hia/
evidence/doh/en/) which recognizes the
following determinants of health:
• The social and economic
environment
• The physical environment
• The person’s individual
characteristics and behaviors
A healthy 21-year-old person may
possess such attributes as a BMI
between 19 and 25, blood pressure
about 120/80 mm mercury, sound
mental health, and the ability to develop
and maintain relationships with other
people. A healthy 21-year-old person
may be able to obtain employment if
desired or circumstances warrant. A
healthy 21-year-old person should be
able to provide food, clothing, and
shelter for themselves and, if desired or
if circumstances warrant, for others.
One would expect that a 21-year-old
person would possess a solid
foundation in literacy (including written
and oral communication skills),
numeracy, and problem solving skills.
As young adults, they may have positive
relationships with friends or family, a
network of peers, and feel that they are
part of a community. Furthermore, a
healthy 21-year-old person is not
defined on the basis of an individual
who is free of disease or disability. If an
individual has a limitation, she or he
may still be able to function well, and
even thrive, in society with the proper
access to care, social support, and
adaptations.
The NCS will measure health as well
as the presence or absence of diseaserelated signs, symptoms, and
limitations. This requires a data
collection protocol that captures a full
description of an individual—a health
profile—rather than just known
determinants of disease and subsequent
outcomes. This is consistent with the
Life Course Health Development model
which ‘‘not only measures an
individual’s deficits but also calculates
his or her health assets (The Millbank
Quarterly 80(3): 433).’’
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
3841
As an organizing principle, the
construction of a data collection
approach around the characteristics of a
healthy 21-year-old person allows the
NCS to identify and measure the full
range of experiences that may later
influence individual outcomes.
Measures must address the range of
potential influences, from individuals,
family, peers, the environment,
communities or the larger society. This
collection will supplement the
conventional measurement of known or
theorized antecedents of disease-related
outcomes. The NCS does not intend to
evaluate each participant using a
particular paradigm as a preferred
outcome, but rather to ensure that
generally accepted health characteristics
can be captured across the spectrum of
the NCS. The NCS is not and cannot be
a national screening program for various
conditions but should be able to identify
a wide range of phenotypic
characteristics. The NCS will emphasize
recording primary signs and symptoms,
capacities and limitations, and a
description of the whole person rather
than diagnosing individuals as having
particular diseases or conditions.
Nonetheless, all relevant information
from medical records, therapeutic
interventions, and descriptions from
participants and care takers will be
captured and become part of the
analytic data sets.
In such a model, however, the linking
of a particular participant with a
particular disease or condition may not
offer all the necessary or even accurate
information about either that individual
or the population at large. By
maintaining a focus on primary signs
and symptoms, performance, any
limitations, trends, developmental
progress, experience, adaptation to
changes in environment and context
and relationships to the people and
world around each participant, the NCS
intends to maintain flexibility and
precision for future analyses.
Health disparities will be addressed
using a definition from the Centers for
Disease Control and Prevention that
notes disease burden, injury, violence,
and health potential as key parameters
(CDC, HHS, 2008). Each participant in
the NCS will be evaluated for each of
these parameters, regardless of any other
demographic or socioeconomic
characteristics. Through this approach,
the NCS can maintain continuity of
purpose through the ever-present
changes in a dynamic society.
In sum, the NCS is proposing the use
of a framework of distal outcomes,
health determinants, primary signs and
symptoms, phenotypic and
environmental descriptions, and capture
E:\FR\FM\23JAN1.SGM
23JAN1
3842
Federal Register / Vol. 79, No. 15 / Thursday, January 23, 2014 / Notices
of parameters associated with health
disparities to guide the selection of the
specific assessments along with their
sequence and frequency. Related
materials with additional information
can be found here: https://
www.nationalchildrensstudy.gov/about/
organization/advisorycommittee/Pages/
January-2014-NCSAC-Meeting-BriefingBook.aspx.
DEPARTMENT OF HOMELAND
SECURITY
3. Information Requested
AGENCY:
This RFI invites the scientific
community, health professionals, and
the general public to provide comments
and suggestions on the proposed
framework of using the characteristics of
a healthy, functional 21-year-old person,
plus the other principles and factors
noted, above for developing Study
content and protocols. Given the
requirements as stated in the Children’s
Health Act of 2000, please include in
responses to the questions below
whether the Study proposed content
framework balances the complex
requirements.
1. Please comment on the validity and
acceptability of using a composite
outcome—the higher-level functions of
a healthy 21-year-old person—as an
operational construct to help frame data
collection.
2. Are there additional outcomes or
developmental endpoints that should be
considered?
3. What factors should the NCS use to
prioritize assessments? Some examples
of factors to consider are:
a. Potential public health impact.
b. Technical feasibility, including
timing of data collection with regard
to potential developmental
vulnerability.
c. Scientific opportunity to address
knowledge gaps and illuminate
developmental pathways.
sroberts on DSK5SPTVN1PROD with NOTICES
This RFI is for planning purposes
only and should not be construed as a
solicitation for applications or
proposals, or as an obligation in any
way on the part of the United States
Federal government. The Federal
government will not pay for the
preparation of any information
submitted or for the government’s use.
Additionally, the government cannot
guarantee the confidentiality of the
information provided.
Dated: January 15, 2014.
Dean J. Coppola,
Acting Director, National Children’s Study,
Eunice Kennedy Shriver National Institute of
Child Health and Human Development.
[FR Doc. 2014–01339 Filed 1–22–14; 8:45 am]
BILLING CODE 4140–01–P
VerDate Mar<15>2010
21:50 Jan 22, 2014
Jkt 232001
U.S. Customs and Border Protection
Agency Information Collection
Activities: Declaration of the Ultimate
Consignee That Articles Were
Exported for Temporary Scientific or
Educational Purposes
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: 30-Day Notice and request for
comments; Extension of an existing
collection of information: 1651–0036.
U.S. Customs and Border
Protection (CBP) of the Department of
Homeland Security will be submitting
the following information collection
request to the Office of Management and
Budget (OMB) for review and approval
in accordance with the Paperwork
Reduction Act: Declaration of the
Ultimate Consignee That Articles Were
Exported for Temporary Scientific or
Educational Purposes. This is a
proposed extension of an information
collection that was previously
approved. CBP is proposing that this
information collection be extended with
no change to the burden hours. This
document is published to obtain
comments from the public and affected
agencies. This proposed information
collection was previously published in
the Federal Register (78 FR 69101) on
November 18, 2013, allowing for a 60day comment period. This notice allows
for an additional 30 days for public
comments. This process is conducted in
accordance with 5 CFR 1320.10.
DATES: Written comments should be
received on or before February 24, 2014
to be assured of consideration.
ADDRESSES: Interested persons are
invited to submit written comments on
this proposed information collection to
the Office of Information and Regulatory
Affairs, Office of Management and
Budget. Comments should be addressed
to the OMB Desk Officer for Customs
and Border Protection, Department of
Homeland Security, and sent via
electronic mail to oira_submission@
omb.eop.gov or faxed to (202) 395–5806.
FOR FURTHER INFORMATION CONTACT:
Requests for additional information
should be directed to Tracey Denning,
U.S. Customs and Border Protection,
Regulations and Rulings, Office of
International Trade, 90 K Street NE.,
10th Floor, Washington, DC 20229–
1177, at 202–325–0265.
SUPPLEMENTARY INFORMATION: CBP
invites the general public and other
Federal agencies to comment on
SUMMARY:
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
proposed and/or continuing information
collections pursuant to the Paperwork
Reduction Act of 1995 (Pub. L.104–13;
44 U.S.C. 3507). The comments should
address: (a) Whether the collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s
estimates of the burden of the collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; (d) ways to
minimize the burden including the use
of automated collection techniques or
the use of other forms of information
technology; and (e) the annual costs
burden to respondents or record keepers
from the collection of information (a
total capital/startup costs and
operations and maintenance costs). The
comments that are submitted will be
summarized and included in the CBP
request for Office of Management and
Budget (OMB) approval. All comments
will become a matter of public record.
In this document CBP is soliciting
comments concerning the following
information collection:
Title: Declaration of the Ultimate
Consignee That Articles Were Exported
for Temporary Scientific or Educational
Purposes.
OMB Number: 1651–0036.
Form Number: None.
Abstract: The Declaration of the
Ultimate Consignee that Articles were
Exported for Temporary Scientific or
Educational Purposes is used to
document duty free entry under
conditions when articles are temporarily
exported solely for scientific or
educational purposes. This declaration,
which is completed by the ultimate
consignee and submitted to CBP by the
importer or the agent of the importer, is
used to assist CBP personnel in
determining whether the imported
articles should be free of duty. It is
provided for under 19 U.S.C. 1202,
HTSUS Subheading 9801.00.40, and 19
CFR 10.67(a)(3) which requires a
declaration to Customs and Border
Protection (CBP) stating that the articles
were sent from the United States solely
for temporary scientific or educational
use and describing the specific use to
which they were put while abroad.
Current Actions: CBP proposes to
extend the expiration date of this
information collection with no change
to the burden hours or to the
information being collected.
Type of Review: Extension (without
change).
Affected Public: Businesses.
Estimated Number of Respondents:
55.
E:\FR\FM\23JAN1.SGM
23JAN1
Agencies
[Federal Register Volume 79, Number 15 (Thursday, January 23, 2014)]
[Notices]
[Pages 3840-3842]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-01339]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Request for Information on the Proposed Framework for Developing
Study Content and Protocols for the National Children's Study
SUMMARY: The National Children's Study (NCS) is soliciting comments and
suggestions from the public on the proposed Study content framework.
The questions solicited in this Request for Information (RFI) focus on
the validity and acceptability of the using a composite outcome for the
higher-level functions of a healthy 21-year-old person as an important
operational construct to help frame data collection throughout the
duration of the study. Responses to this RFI will be used to inform
Study protocol development.
DATES: The National Children's Study Request for Information is open
for public comment for a period of 30 days. Comments must be received
by February 24, 2014 to ensure consideration. After the public comment
period has closed, the comments received by the NCS will be considered
in a timely manner by the Eunice Kennedy Shriver National Institute of
Child Health and Human Development and the National Children's Study.
ADDRESSES: Questions about this request for information should be
directed to Kate Winseck, MSW, The National Children's Study, Eunice
Kennedy Shriver National Institute of Child Health and Human
Development, National Institutes of Health, 6100 Executive Blvd., Rm.
5C01, Bethesda, MD 20891, NCS_RFI@mail.nih.gov, 301-594-9147.
SUPPLEMENTARY INFORMATION: The National Children's Study is a
congressionally-mandated longitudinal birth cohort study intended to
examine the effects of environmental exposures on the growth,
development, and wellbeing of children. The NCS was mandated by the
Children's Health Act of 2000 (Pub. L. 106-310).
1. Goals and Requirements
The primary objective of the NCS is to conduct a national
longitudinal study of environmental influences (including physical,
chemical, biological, and psychosocial) on children's health and
development. These factors include environmental exposures (with a
broad definition of environment) and biological/genetic contexts. The
Study objectives stated in the Children's Health Act of 2000 include:
(1) Evaluate the effects of both chronic and intermittent exposures on
child health and human development; (2) investigate basic mechanisms of
developmental disorders and environmental factors; (3) incorporate
behavioral, emotional, educational, and contextual consequences to
enable a complete assessment of the physical, chemical, biological and
psychosocial environmental influences on children's well-being; (4)
gather data from diverse populations of children including prenatal
exposures; and (5) consider health disparities among children.
2. Proposed Study Content Framework
The NCS proposes to organize data collection priorities to support
measurement of health and healthy development at critical stages. This
requires understanding and identifying
[[Page 3841]]
known and potential factors that may influence health outcomes and
characteristics along the developmental spectrum. For example, data
collected during pregnancy are designed to look not only at antecedents
of disease but also to look for factors associated with health. Which
exposures are associated with a healthy, full term infant? What factors
are predictive of a normal birth weight? What factors are associated
with normal neurologic development? Areas that will be examined
include, but are not limited to (1) physical factors such as maternal
and paternal height, weight and Body Mass Index (BMI); (2) health
behaviors such as sleep, diet and physical activity; (3) outcomes of
past pregnancies and other medical conditions and history; (4)
medication use (including alternative and complementary medicines); (5)
presence or absence of components of the physical environment, such as
noise, mold and mildew, pets, chemicals, and environmental tobacco
smoke; and (6) psychosocial factors, such as social support, social
networks, and psychological well-being and other factors that may
protect and mediate reactions to stress. Biological and environmental
samples will be collected to allow examination of in-utero exposures.
The NCS intends to follow all children from birth until they reach
age 21, an endpoint consistent with the Food and Drug Administration
Amendments Act of 2007 that defines ``pediatric patients'' as ``those
who are 21 years of age or younger at the time of diagnosis or
treatment (FDA Amendments Act of 2007).'' As such it is important to
identify the characteristics of a healthy 21-year-old person. Reaching
age 21 is one of many important developmental milestones and it serves
as a useful life stage for illustration of how the NCS data collection
framework can be organized.
To ensure the Study content framework is comprehensive, the NCS is
working with subject matter experts to characterize health. As
developmental trajectories are multi-dimensional, multi-directional,
and multi-level, this effort not only helps characterize the distal end
of the childhood developmental trajectory, but also identifies
potential antecedent factors that could be measured earlier in life in
assessing exposures that may contribute to later outcomes. For example,
supportive family relationships during adolescence has been associated
with positive outcomes ranging from reduced risk of poor mental health
to higher levels of interpersonal and occupational functioning; these
outcomes being independent of any effect of gender, socioeconomic
status, or family disruption, for example death or divorce (Child
Adolescent Mental Health 16(1): 30-37).
At 21 years old, the thriving individual is a manifestation of
complex, dynamic, non-linear developmental processes that are products
of personal characteristics (including genetics), person-to-person, and
person-to-environment interactions in the broadest sense. This
characterization is consistent with the World Health Organization (WHO)
construct (https://www.who.int/hia/evidence/doh/en/) which recognizes
the following determinants of health:
The social and economic environment
The physical environment
The person's individual characteristics and behaviors
A healthy 21-year-old person may possess such attributes as a BMI
between 19 and 25, blood pressure about 120/80 mm mercury, sound mental
health, and the ability to develop and maintain relationships with
other people. A healthy 21-year-old person may be able to obtain
employment if desired or circumstances warrant. A healthy 21-year-old
person should be able to provide food, clothing, and shelter for
themselves and, if desired or if circumstances warrant, for others. One
would expect that a 21-year-old person would possess a solid foundation
in literacy (including written and oral communication skills),
numeracy, and problem solving skills. As young adults, they may have
positive relationships with friends or family, a network of peers, and
feel that they are part of a community. Furthermore, a healthy 21-year-
old person is not defined on the basis of an individual who is free of
disease or disability. If an individual has a limitation, she or he may
still be able to function well, and even thrive, in society with the
proper access to care, social support, and adaptations.
The NCS will measure health as well as the presence or absence of
disease-related signs, symptoms, and limitations. This requires a data
collection protocol that captures a full description of an individual--
a health profile--rather than just known determinants of disease and
subsequent outcomes. This is consistent with the Life Course Health
Development model which ``not only measures an individual's deficits
but also calculates his or her health assets (The Millbank Quarterly
80(3): 433).''
As an organizing principle, the construction of a data collection
approach around the characteristics of a healthy 21-year-old person
allows the NCS to identify and measure the full range of experiences
that may later influence individual outcomes. Measures must address the
range of potential influences, from individuals, family, peers, the
environment, communities or the larger society. This collection will
supplement the conventional measurement of known or theorized
antecedents of disease-related outcomes. The NCS does not intend to
evaluate each participant using a particular paradigm as a preferred
outcome, but rather to ensure that generally accepted health
characteristics can be captured across the spectrum of the NCS. The NCS
is not and cannot be a national screening program for various
conditions but should be able to identify a wide range of phenotypic
characteristics. The NCS will emphasize recording primary signs and
symptoms, capacities and limitations, and a description of the whole
person rather than diagnosing individuals as having particular diseases
or conditions. Nonetheless, all relevant information from medical
records, therapeutic interventions, and descriptions from participants
and care takers will be captured and become part of the analytic data
sets.
In such a model, however, the linking of a particular participant
with a particular disease or condition may not offer all the necessary
or even accurate information about either that individual or the
population at large. By maintaining a focus on primary signs and
symptoms, performance, any limitations, trends, developmental progress,
experience, adaptation to changes in environment and context and
relationships to the people and world around each participant, the NCS
intends to maintain flexibility and precision for future analyses.
Health disparities will be addressed using a definition from the
Centers for Disease Control and Prevention that notes disease burden,
injury, violence, and health potential as key parameters (CDC, HHS,
2008). Each participant in the NCS will be evaluated for each of these
parameters, regardless of any other demographic or socioeconomic
characteristics. Through this approach, the NCS can maintain continuity
of purpose through the ever-present changes in a dynamic society.
In sum, the NCS is proposing the use of a framework of distal
outcomes, health determinants, primary signs and symptoms, phenotypic
and environmental descriptions, and capture
[[Page 3842]]
of parameters associated with health disparities to guide the selection
of the specific assessments along with their sequence and frequency.
Related materials with additional information can be found here: https://www.nationalchildrensstudy.gov/about/organization/advisorycommittee/Pages/January-2014-NCSAC-Meeting-Briefing-Book.aspx.
3. Information Requested
This RFI invites the scientific community, health professionals,
and the general public to provide comments and suggestions on the
proposed framework of using the characteristics of a healthy,
functional 21-year-old person, plus the other principles and factors
noted, above for developing Study content and protocols. Given the
requirements as stated in the Children's Health Act of 2000, please
include in responses to the questions below whether the Study proposed
content framework balances the complex requirements.
1. Please comment on the validity and acceptability of using a
composite outcome--the higher-level functions of a healthy 21-year-old
person--as an operational construct to help frame data collection.
2. Are there additional outcomes or developmental endpoints that
should be considered?
3. What factors should the NCS use to prioritize assessments? Some
examples of factors to consider are:
a. Potential public health impact.
b. Technical feasibility, including timing of data collection with
regard to potential developmental vulnerability.
c. Scientific opportunity to address knowledge gaps and illuminate
developmental pathways.
This RFI is for planning purposes only and should not be construed
as a solicitation for applications or proposals, or as an obligation in
any way on the part of the United States Federal government. The
Federal government will not pay for the preparation of any information
submitted or for the government's use. Additionally, the government
cannot guarantee the confidentiality of the information provided.
Dated: January 15, 2014.
Dean J. Coppola,
Acting Director, National Children's Study, Eunice Kennedy Shriver
National Institute of Child Health and Human Development.
[FR Doc. 2014-01339 Filed 1-22-14; 8:45 am]
BILLING CODE 4140-01-P